Collins Stewart Maintains a 'Buy' on King Pharmaceuticals (KG); Three Key Reasons to Own Shares
Tweet Send to a Friend
Collins Stewart maintains a 'Buy' on King Pharmaceuticals (NYSE: KG), raises price target from $10 to $11.
Collins analyst says ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Collins analyst says ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
